RightFit Trial Directory

Sickle Cell Disease clinical trials in Greenville, NC

13 recruiting sickle cell disease studies with a site in Greenville, NC.

All trials in Greenville, NC · All Sickle Cell Disease trials

RecruitingPhase 3NCT06439082

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Sponsor: Novartis Pharmaceuticals

Greenville, NC · Winston-Salem, NC · +15 more sites

RecruitingPhase 1 / Phase 2NCT06546670

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

Sponsor: Novartis Pharmaceuticals

Charlotte, NC · Greenville, NC · +7 more sites

RecruitingNot applicableNCT06374238

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Sponsor: University of Pittsburgh

Durham, NC · Greenville, NC · +12 more sites

RecruitingPhase 2NCT06699849

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Sponsor: CSL Behring

Greenville, NC · +19 more sites

RecruitingPhase not listedNCT06071377

Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

Sponsor: National Alliance for Sickle Cell Centers

Chapel Hill, NC · Durham, NC · Greenville, NC · +5 more sites

RecruitingPhase 1NCT07187973

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Sponsor: Disc Medicine, Inc

Durham, NC · Greenville, NC · +9 more sites

RecruitingPhase 3NCT06609226

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Sponsor: Novo Nordisk A/S

Charlotte, NC · Durham, NC · Greenville, NC · +36 more sites

RecruitingPhase 3NCT06612268

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Sponsor: Novo Nordisk A/S

Durham, NC · Greenville, NC · +47 more sites

RecruitingPhase 2 / Phase 3NCT05431088

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Sponsor: Pfizer

Chapel Hill, NC · +43 more sites

RecruitingPhase 1 / Phase 2NCT06481306

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Sponsor: Bristol-Myers Squibb

Greenville, NC · +18 more sites

RecruitingPhase not listedNCT04398628

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Sponsor: American Thrombosis and Hemostasis Network

Chapel Hill, NC · Charlotte, NC · Greenville, NC · +73 more sites

RecruitingPhase 4NCT04657822

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

Sponsor: Novartis Pharmaceuticals

Greenville, NC · +5 more sites

Not yet recruitingPhase 3NCT06989567

A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis

Sponsor: Asklepion Pharmaceuticals, LLC

Greenville, NC · +5 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.